VF
BRTX icon

Virtu Financial’s BioRestorative Therapies BRTX Stock Holding History

Virtu Financial’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,351
Closed -$35K – 1699
2025
Q3 		$35K Buy
24,351
+12,319
+102% +$19.1K ﹤0.01% 1195
2025
Q2 		$20K Buy
+12,032
New +$20.9K ﹤0.01% 1252

Other funds holding BRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
NF
Napier Financial Braintree, Massachusetts $480M AUM
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Virtu Financial's BRTX Position: Q4 2025 in Review

Virtu Financial sold out of BioRestorative Therapies (BRTX) in Q4 2025, closing a stake of 24,351 shares — an estimated $35K sold.

Virtu Financial first reported a position in BRTX in Q2 2025 and held it in 2 quarters. The position peaked at $35K in Q3 2025. 13 funds tracked by Wall St. Rank hold BRTX as of Q4 2025.

  • Virtu Financial reported no remaining BioRestorative Therapies position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 24,351 BioRestorative Therapies shares in Q4 2025, an estimated $35K.
  • Virtu Financial first reported a position in BioRestorative Therapies in Q2 2025 and held it in 2 quarters.
  • Virtu Financial's BioRestorative Therapies position peaked at $35K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.